David Brenneman serves as a key strategist for leading companies and investors, advising them on the antitrust aspects of mergers and acquisitions, joint ventures, and other strategic transactions.

David draws on more than 15 years of experience defending major transactions before US and international competition law authorities. He routinely advises clients through their highest-stakes antitrust matters, including:

  • Global deal clearance strategy
  • Second requests
  • Premerger conduct counseling
  • Clayton Act Section 8 investigations
  • Competition investigations brought by enforcers

David advises corporations and global asset managers across a range of heavily regulated industries, from technology and communications to life sciences and financial services. He coordinates winning global strategies for clients facing deal review proceedings in multiple jurisdictions, including before the US Department of Justice (DOJ) Antitrust Division, the Federal Trade Commission (FTC), and the European Commission.

David also frequently writes on recent developments in competition law, and regularly provides antitrust counseling to trade associations, standard setting organizations, and other consortiums of industry participants.

David’s representative experience includes advising:

  • Several leading asset managers, including Apollo Global Management, DigitalBridge Group, and EQT Partners, in connection with dozens of strategic multi-billion dollar transactions in scrutinized industries including healthcare, telecommunications, publishing, and technology, among others*
  • Energy Harbor in connection with its US$6.3 billion sale to Vistra*
  • Intercontinental Exchange in its US$16 billion proposed acquisition of Black Knight*
  • Perrigo Co. plc in connection with:
    • Its US$2.1 billion acquisition of Hera SAS (HRA Pharma)*
    • Mylan N.V.’s unsolicited offer to acquire Perrigo Co. plc*
  • A leading asset manager in connection with several multibillion-dollar transactions in the publishing, healthcare, and technology industries, among others*
  • A leading asset manager in connection with several multibillion-dollar acquisitions in the communications industry*
  • A leading asset manager in connection with several multi-hundred million-dollar acquisitions in the professional services industry*
  • A leading publishing company in connection with multiple transactions in the publishing industry*
  • A leading healthcare company in connection with several multibillion- and multimillion-dollar acquisitions and dispositions*
  • A leading technology company in connection with a global joint venture*
  • Several leading asset managers in connection with separate DOJ investigations with respect to Section 8 of the Clayton Act*
  • A leading life sciences company in connection with an FTC investigation with respect to Section 5 of the FTC Act*
  • Aurobindo in connection with its proposed acquisition of Sandoz’s generic product portfolio*
  • Securus Technologies (Platinum Equity) in connection with its proposed acquisition of Inmate Calling Solutions*
  • Intercontinental Exchange in connection with its acquisition of Standard & Poor’s Securities and Evaluations business from McGraw Hill Financial*
  • Pfizer in connection with:
    • Its proposed US$160 billion acquisition of Allergan plc*
    • Its US$68 billion acquisition of Wyeth*

*Matter handled prior to joining Latham

Bar Qualification

  • District of Columbia
  • New York

Education

  • JD, Georgetown University Law Center, 2008
  • BA, University of Maryland, College Park, 2005